[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336497-105":59,"doc-detail-336497-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","the-met-family-of-receptor-tyrosine-kinases-promotes-a-shift-to-pro-tumor-metabolism-review","The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism - Review","","Cancer development and growth depend on pro-tumor metabolic reprogramming. Cancer cells typically downshift oxidative phosphorylation and increase reliance on glycolysis, a change linked to receptor tyrosine kinase (RTK) signaling. The MET family, composed of MET and RON (MST1R), is overexpressed across tumor types and correlates with worse prognosis. MET and RON enhance glycolysis via MYC-driven transcription of glycolytic enzymes, and promote cholesterol biosynthesis through SREBP2-induced pathways.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-met-family-of-receptor-tyrosine-kinases-promotes-a-shift-to-pro-tumor-metabolism-review/336497/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-met-family-of-receptor-tyrosine-kinases-promotes-a-shift-to-pro-tumor-metabolism-review/336497.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How do MET and RON signaling promote pro-tumor glycolysis and cholesterol biosynthesis?","Question",{"text":112,"@type":113},"Both MET and RON promote increased glycolysis by upregulating key glycolytic enzymes through MYC transcription factor activity. They also enhance cholesterol biosynthesis downstream of glycolysis by upregulating SREBP2-induced enzymes via CTTNB1.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},336497,1790129489,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":41,"preview_page_count":19,"preview_urls":137},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Review  \nThe MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism  \nJames C. Davis 1 and Susan E. Waltz 1,2, *  \nCitation: Davis, J.C.; Waltz, S.E. The MET Family of Receptor Tyrosine Kinases Promotes a Shift to  \nPro-Tumor Metabolism. Genes 2024, 15, 953. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes15070953  \nAcademic Editor: Gael Roue  \nReceived: 26 June 2024  \nRevised: 16 July 2024  \nAccepted: 19 July 2024  \nPublished: 20 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Cancer Biology, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA  \n2 Research Service, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH 45220, USA  \n* Correspondence: [susan.waltz@uc.edu](susan.waltz@uc.edu); Tel.: +1-513-558-8675  \nAbstract: The development and growth of cancer is fundamentally dependent on pro-tumor changes in metabolism. Cancer cells generally shift away from oxidative phosphorylation as the primary source of energy and rely more heavily on glycolysis. Receptor tyrosine kinases (RTKs) are a type of receptor that is implicated in this shift to pro-tumor metabolism. RTKs are important drivers of cancer growth and metastasis. One such family of RTKs is the MET family, which consists of MET and RON (MST1R) . The overexpression of either MET or RON has been associated with worse cancer patient prognosis in a variety of tumor types. Both MET and RON signaling promote increased glycolysis by upregulating the expression of key glycolytic enzymes via increased MYC transcription factor activity. Additionally, both MET and RON signaling promote increased cholesterol biosynthesis downstream of glycolysis by upregulating the expression of SREBP2-induced cholesterol biosynthesis enzymes via CTTNB1 . These changes in metabolism, driven by RTK activity, provide potential targets in limiting tumor growth and metastasis via pharmacological inhibition or modiﬁcations in diet. This review summarizes pro-tumor changes in metabolism driven by the MET family of RTKs. In doing so, we will offer our unique perspective on metabolic pathways that drive worse patient prognosis and provide suggestions for future study.  \nKeywords: RTK; RON; c-MET; MET; MST1R; cancer; metabolism  \n1. Introduction  \nCancer is the second most common cause of death in the U.S. In 2023, it was estimated that more than 1.9 million new cancer diagnoses and around 600,000 deaths from cancer would occur [1] . To limit the number of deaths, it is important to identify the molecular drivers of cancer.  \nA key mechanism that drives the growth of cancer is a shift to a pro-tumor form of metabolism [2] . Non-cancerous cells rely primarily on oxidative phosphorylation for ATP production, while cancer cells rely much more heavily on glycolysis for ATP production, a phenomenon known as the Warburg effect [2] . In addition to increased glucose ﬂux, in cancerous cells, pyruvate is reduced into lactate at a higher rate than in noncancerous cells [3] . Transport of lactate out of the tumor cell into the tumor microenvironment has multiple functions. Lactate can act as an important energy source and promote the polarization of macrophages into a pro-tumor state [4] . Thus, the shift to a pro-tumor form of metabolism produces more energy and helps maintain a preferential microenvironment for increased tumor growth, metastasis, and treatment resistance [5] . Therefore, targeting pro-tumor metabolism is an important opportunity to treat cancer.  \nReceptor tyrosine kinases [RTKs] are a type of protein that helps facilitate the shift to a pro-tumor metabolism. RTKs are signal","cbCaiqDBC8g0sK0J","https://ap.wps.com/l/cbCaiqDBC8g0sK0J","pdf",993671,12,"English","# Introduction\n# MET Family Signaling in Pro-Tumor Glycolysis","[{\"question\":\"How do MET and RON signaling promote pro-tumor glycolysis and cholesterol biosynthesis?\",\"answer\":\"Both MET and RON promote increased glycolysis by upregulating key glycolytic enzymes through MYC transcription factor activity. They also enhance cholesterol biosynthesis downstream of glycolysis by upregulating SREBP2-induced enzymes via CTTNB1.\"}]","The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism - Review | PDF",1790015350,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e7d908d85dfbf541202ad5a80daa720.webp",983,1390,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0380998c4f8b72f7bb199aaf5ffb7ad.webp",982,1388,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbc7cfe2e24ec45af86a12728afeb43d.webp",981,1387,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b9363e538e6a9b0e578ba267491ebcd.webp",980,1385]